Surrogates, substudies, and real clinical end points in trials of drug-eluting stents

Journal of the American College of Cardiology

Volumn 45, Issue 8, 2005, Pages 1206-1212

  Kereiakes, Dean J ^a   Kuntz, Richard E ^b   Mauri, Laura ^b   Krucoff, Mitchell W ^c  

^a The Carl & Edyth Lindner Center for Research & Education   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

'TAXUS'; CYPHER; PACLITAXEL; RAPAMYCIN;

ANGIOGRAPHY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FOOD AND DRUG ADMINISTRATION; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; INTIMA; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; REVIEW;

EID: 17144387004     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.01.005     Document Type: Editorial

References (34)

1. A.M. Lincoff, J.J. Popma, S.G. Ellis Abrupt vessel closure complicating coronary angioplasty; clinical, angiographic and therapeutic profile J Am Coll Cardiol 19 1992 926 935
2. R.E. Kuntz, R. Piana, R.M. Pomerantz Changing incidence and management of abrupt closure following coronary intervention in the new device era Cathet Cardiovasc Diagn 27 1992 183 190
3. N.A. Scott, W.S. Weintraub, S.F. Carlin Recent changes in the management and outcome of acute closure after percutaneous transluminal coronary angioplasty Am J Cardiol 71 1993 1158 1163
4. P.W. Serruys, P. deJaegere, F. Kiemeneij Benstent Study Group A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease N Engl J Med 31 1994 489 495
5. D.L. Fischman, M.D. Leon, D.S. Baim A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease N Engl J Med 331 1994 496 501
6. P.W. Serruys, H. Emanuelsson, W. van der Giessen Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II pilot study Circulation 93 1996 412 422
7. A. Betriu, M. Masotti, A. Serra Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START) a four-year follow-up J Am Coll Cardiol 34 1999 1498 1506
8. R. Moreno, C. Fernandez, F. Alfonso Coronary stenting versus balloon angioplasty in small vessels a meta-analysis from 11 randomized studies J Am Coll Cardiol 43; 2004 1964 1972
9. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
10. G.W. Stone, S.G. Ellis, D.A. Cox TAXUS-IV Investigators A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
11. D.J. Cohen, A. Bakhai, C. Shi Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial Circulation 110 2004 508 514
12. S.G. Ellis, J.J. Popma, J.M. Lasala Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation analysis from the TAXUS-IV trial J Am Coll Cardiol 45 2005 1193 1200
13. J.B. Hermiller, A. Raizner, L. Cannon TAXUS-IV Investigators Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus the TAXUS-IV trial J Am Coll Cardiol 45 2005 1172 1179
14. G. Dangas, S.G. Ellis, R. Shlofmitz TAXUS-IV Investigators Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending artery J Am Coll Cardiol 45 2005 1186 1192
15. A.J. Lansky, R.A. Costa, M. Mooney TAXUS-IV Investigators Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease J Am Coll Cardiol 45 2005 1180 1185
16. J.W. Moses, R. Mehran, E. Nikolsky Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes analysis from the TAXUS-IV trial J Am Coll Cardiol 45 2005 1165 1171
17. N.J. Weissman, J. Koglin, D.A. Cox Polymer-based, paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial J Am Coll Cardiol 45 2005 1201 1205
18. R.E. Kuntz, D.S. Baim Defining coronary restenosis newer clinical and angiographic paradigms Circulation 88 1993 1310 1323
19. D.E. Cutlip, M.S. Chauhan, D.S. Baim Clinical restenosis after coronary stenting perspectives from multicenter clinical trials J Am Coll Cardiol 40 2002 2082 2089
20. M.J. Post, C. Borst, R.E. Kuntz The relative importance of arterial remodeling compared to intimal hyperplasia in lumen renarrowing following balloon angioplasty a study in the normal rabbit and the hypercholesterolemic Yucatan micropig Circulation 89 1994 2816 2821
21. R.E. Kuntz, R.D. Safian, M.J. Levine Novel approach to the analysis of restenosis after the use of three new coronary devices J Am Coll Cardiol 91 1992 1493 1499
22. B.J. Rensing, W.R. Hermans, J.W. Deckers, P.J. de Feyter, J.G. Tijssen, P.W. Serruys Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near Gaussian distribution a quantitative angiographic study in 1,445 successfully dilated lesions J Am Coll Cardiol 19 1992 939 945
23. A.J. Lansky, R.A. Costa, G.S. Mintz Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions angiographic follow-up of the DELIVER clinical trial Circulation 109 2004 1948 1954
24. P.A. Lemos, N. Mercado, R.T. van Domburg, R.E. Kuntz, W.W. O'Neill, P.W. Serruys Comparison of late luminal loss response pattern after sirolimus-eluting stent implantation or conventional stenting Circulation 110 2004 3199-20
25. L. Mauri, E.J. Orav, A.J. O'Malley Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents Circulation 111 2005 321 327
26. L.D. Fisher Active control trials what about a placebo? A method illustrated with clopidogrel, aspirin and placebo Am J Cardiol 141 2001 26 32
27. H.C. Bucher, G.H. Guyatt, L.E. Griffith, S.D. Walter The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials J Clin Epidemiol 50 1997 683 691
28. W.W. Hauck, S. Anderson Some issues in the design and analysis of equivalence trials Drug Inf J 33 1999 109 118
29. V. Hasselblad, D.F. Kong Statistical methods for comparison to placebo in active-control trials Drug Inf J 35 2001 435 449
30. G.W. Stone, S.G. Ellis, D.A. Cox One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent the TAXUS-IV trial Circulation 109 2004 1942 1947
31. S.J. Pocock, S.E. Assmann, L.E. Enos, L.E. Kasten Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting current practice and problems Stat Med 21 2002 2917 2930
32. S.J. Pocock Clinical trials with multiple outcomes a statistical perspective on their design, analysis and interpretation Control Clin Trials 18 1997 530 545
33. I. Moussa, M.B. Leon, D. Baim Impact of sirolimus-eluting stents on outcome in diabetic patients a SIRIUS (SIRolImUS-coated BX Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy Circulation 109 2004 2273 2278
34. N. Sawhney, J.W. Moses, M.B. Leon Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents Circulation 110 2004 374 379